Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort). En savoir plus sur Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort).
Revision of biliary sphincterotomy by re-cut, balloon dilation or temporary stenting: comparison of clinical outcome and complication rate (with video). En savoir plus sur Revision of biliary sphincterotomy by re-cut, balloon dilation or temporary stenting: comparison of clinical outcome and complication rate (with video).
Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity. En savoir plus sur Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
The European Section and Board of Gastroenterology and Hepatology. En savoir plus sur The European Section and Board of Gastroenterology and Hepatology.
MCR-1 and OXA-48 in vivo acquisition in KPC-producing Escherichia coli after colistin treatment. En savoir plus sur MCR-1 and OXA-48 in vivo acquisition in KPC-producing Escherichia coli after colistin treatment.
Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study. En savoir plus sur Bivalirudin infusion to reduce ventricular infarction: the open-label, randomised Bivalirudin Infusion for Ventricular InfArction Limitation (BIVAL) study.
[The effects of inhaled steroids withdrawal in COPD]. En savoir plus sur [The effects of inhaled steroids withdrawal in COPD].
France: coronary and structural heart interventions from 2010 to 2015. En savoir plus sur France: coronary and structural heart interventions from 2010 to 2015.
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing. En savoir plus sur Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003. En savoir plus sur Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003.